Reference : The use of platelet-rich plasma (PRP) to treat chronic tendinopathies: a technical an...
Scientific journals : Article
Human health sciences : Orthopedics, rehabilitation & sports medicine
Human health sciences : Laboratory medicine & medical technology
http://hdl.handle.net/2268/213268
The use of platelet-rich plasma (PRP) to treat chronic tendinopathies: a technical analysis
English
Kaux, Jean-François mailto [Université de Liège > Département des sciences de la motricité > Médecine physique, réadaptation et traumatologie du sport >]
Emonds-Alt, Thibault [Centre Hospitalier Universitaire de Liège - CHU > > Service de médecine de l'appareil locomoteur >]
In press
Platelets
Taylor & Francis
Yes (verified by ORBi)
International
0953-7104
1369-1635
Abingdon
United Kingdom
[en] Collection ; optimization ; platelet-rich plasma ; PRP ; standardization ; tendinopathies
[en] Platelet-rich plasma (PRP) is blood plasma with a high concentration of autologous platelets
which constitute an immense reservoir of growth factors. The clinical use of PRP is widespread
in various medical applications.
Although highly popular with athletes, the use of PRP for the treatment of tendinopathies
remains scientifically controversial, particularly due to the diversity of products that go by the
name of “PRP.” To optimize its use, it is important to look at the various stages of obtaining
PRP.
In this literature review, we take a closer look at eight parameters which may influence the
quality of PRP: 1) anticoagulants used to preserve the best platelet function, 2) the speed of
centrifugation used to extract the platelets, 3) the platelet concentrations obtained, 4) the
impact of the concentration of red and while blood cells on PRP actions, 5) platelet activators
encouraging platelet degranulation and, hence, the release of growth factors, and 6) the use or
nonuse of local anesthetics when carrying out infiltration. In addition to these parameters, it
may be interesting to analyze other variables such as 7) the use of ultrasound guidance during
the injection with a view to determining the influence they have on potential recovery.
http://hdl.handle.net/2268/213268
10.1080/09537104.2017.1336211

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
The use of platelet rich plasma to treat chronic tendinopathies A technical analysis.pdfPublisher postprint557.76 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.